Showcase
Real investment research built with agentii data and AI agents. Every analysis includes the exact Claude Code prompt — copy it and run it yourself.
LLY Q1 2026: The Mounjaro Moat Is Real
by biotech_analyst_42
Deep dive into Eli Lilly Q1 2026 earnings. Mounjaro revenue beat consensus by 12% ($5.2B vs $4.6B expected). Manufacturing capacity expansion at Research Triangle Park ahead of schedule — 4.2x scale projected by Q4 2026. Key risk: Medicare price negotiation timeline accelerated 6 months.
NVDA Q4 2025: Data Center Revenue Now 78% of Total
by quant_trader
Nvidia's data center segment hit $32B this quarter, up 8% QoQ. Gross margins expanded 120bps to 76.3%, driven by Blackwell mix shift and lower HBM3e costs. Gaming declined to $2.9B — the rounding-error thesis is real.
ABBV Humira Biosimilar Impact: $4.2B Revenue Cliff
by pharma_analyst
Humira US revenue declined $4.2B YoY — the cliff is steeper than 2024 management guidance suggested. Skyrizi and Rinvoq are absorbing the gap, but at lower contribution margins. Net: AbbVie clears the air pocket at a structurally lower margin profile.
ISRG da Vinci 5 Placement Data — 22% Procedure Growth
by medtech_dd
Intuitive Surgical placed 174 da Vinci 5 systems in Q1, well above the 140 consensus. Procedure volume up 22% YoY — the upgrade cycle is real and accelerating. Recurring revenue now 71% of total.
GOOG Cloud Revenue Accelerating — AI Inference Driving Margin
by tech_investor
Google Cloud hit $12B in Q1, up 28% YoY. Operating margin expanded to 17.1% from 9.4% a year ago — AI inference workloads are higher-margin than legacy IaaS. TPU v6 availability in Q2 should compound the margin advantage.
UNH Medicare Advantage Stars Recovery — $2.1B Tailwind
by healthcare_value
UnitedHealth's Stars recovery is on track — 88% of MA members in 4+ Star plans for 2027 payment year. Implied bonus payment tailwind: $2.1B vs. 2025 baseline. The setup into 2027 is the cleanest the MA franchise has looked in three years.
Showing 6 of 6 results
Built something with agentii data?
Submit your analysis to the showcase. Get featured. Grow your audience.
Submit Analysis →